Toll Free: 1-888-928-9744

INSYS Therapeutics, Inc. - Product Pipeline Review - 2014

Published: May, 2014 | Pages: 39 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

INSYS Therapeutics, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Insys Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Insys Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Insys Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Insys Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Insys Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Insys Therapeutics, Inc.'s pipeline products

Reasons to buy

- Evaluate Insys Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Insys Therapeutics, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Insys Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Insys Therapeutics, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Insys Therapeutics, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Insys Therapeutics, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
INSYS Therapeutics, Inc. Snapshot 5
INSYS Therapeutics, Inc. Overview 5
Key Information 5
Key Facts 5
INSYS Therapeutics, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
INSYS Therapeutics, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
INSYS Therapeutics, Inc. - Pipeline Products Glance 11
INSYS Therapeutics, Inc. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
INSYS Therapeutics, Inc. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
INSYS Therapeutics, Inc. - Drug Profiles 14
dronabinol 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
docetaxel 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
paclitaxel 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
cintredekin besudotox 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
buprenorphine hydrochloride 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
cannabidiol 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
diclofenac 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
ketorolac tromethamine 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
ondansetron hydrochloride 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
sildenafil citrate 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
INSYS Therapeutics, Inc. - Pipeline Analysis 28
INSYS Therapeutics, Inc. - Pipeline Products by Target 28
INSYS Therapeutics, Inc. - Pipeline Products by Route of Administration 30
INSYS Therapeutics, Inc. - Pipeline Products by Molecule Type 31
INSYS Therapeutics, Inc. - Pipeline Products by Mechanism of Action 32
INSYS Therapeutics, Inc. - Recent Pipeline Updates 34
INSYS Therapeutics, Inc. - Dormant Projects 35
INSYS Therapeutics, Inc. - Discontinued Pipeline Products 36
Discontinued Pipeline Product Profiles 36
SS1(dsFv)-PE38 36
INSYS Therapeutics, Inc. - Locations And Subsidiaries 37
Head Office 37
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 39
Disclaimer 39
List of Tables
INSYS Therapeutics, Inc., Key Information 5
INSYS Therapeutics, Inc., Key Facts 5
INSYS Therapeutics, Inc. - Pipeline by Indication, 2014 8
INSYS Therapeutics, Inc. - Pipeline by Stage of Development, 2014 9
INSYS Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 10
INSYS Therapeutics, Inc. - Phase II, 2014 11
INSYS Therapeutics, Inc. - Phase I, 2014 12
INSYS Therapeutics, Inc. - Preclinical, 2014 13
INSYS Therapeutics, Inc. - Pipeline by Target, 2014 29
INSYS Therapeutics, Inc. - Pipeline by Route of Administration, 2014 30
INSYS Therapeutics, Inc. - Pipeline by Molecule Type, 2014 31
INSYS Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 33
INSYS Therapeutics, Inc. - Recent Pipeline Updates, 2014 34
INSYS Therapeutics, Inc. - Dormant Developmental Projects,2014 35
INSYS Therapeutics, Inc. - Discontinued Pipeline Products, 2014 36 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify